Management tracks: Nordic Nanovector, Ra

Blood cancer company Nordic Nanovector ASA (OSE:NANO) appointed CFO Tone Kvåle as interim CEO.

Complement-mediated disease company Ra Pharmaceuticals Inc. (NASDAQ:RARX) hired John King as chief commercial officer. King was VP of the U.S. neurology business unit at Alexion Pharmaceuticals Inc. (NASDAQ:ALXN)...